# Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms

> **NCT07377929** · — · RECRUITING · sponsor: **Benaroya Research Institute** · enrollment: 20 (estimated)

## Conditions studied

- Benign Prostatic Hypertrophy (BPH)
- Lower Urinary Track Symptoms

## Interventions

- **OTHER:** Survey using a questionnaire.

## Key facts

- **NCT ID:** NCT07377929
- **Lead sponsor:** Benaroya Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-19
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377929, "Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07377929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*